OBJECTIVE: While there has been considerable concern over possible adverse effects of psychostimulants on brain development, this issue has not been examined in a prospective study. The authors sought to determine prospectively whether psychostimulant treatment for attention deficit hyperactivity disorder (ADHD) was associated with differences in the development of the cerebral cortex during adolescence. METHOD: Change in cortical thickness was estimated from two neuroanatomic MRI scans in 43 youths with ADHD. The mean age at the first scan was 12.5 years, and at the second scan, 16.4 years. Nineteen patients not treated with psychostimulants between the scans were compared with an age-matched group of 24 patients who were treated with psychostimulants. Further comparison was made against a template derived from 620 scans of 294 typically developing youths without ADHD. RESULTS: Adolescents taking psychostimulants differed from those not taking psychostimulants in the rate of change of the cortical thickness in the right motor strip, the left middle/inferior frontal gyrus, and the right parieto-occipital region. The group difference was due to more rapid cortical thinning in the group not taking psychostimulants (mean cortical thinning of 0.16 mm/year [SD=0.17], compared with 0.03 mm/year [SD=0.11] in the group taking psychostimulants). Comparison against the typically developing cohort without ADHD showed that cortical thinning in the group not taking psychostimulants was in excess of age-appropriate rates. The treatment groups did not differ in clinical outcome, however. CONCLUSIONS: These findings show no evidence that psychostimulants were associated with slowing of overall growth of the cortical mantle.
OBJECTIVE: While there has been considerable concern over possible adverse effects of psychostimulants on brain development, this issue has not been examined in a prospective study. The authors sought to determine prospectively whether psychostimulant treatment for attention deficit hyperactivity disorder (ADHD) was associated with differences in the development of the cerebral cortex during adolescence. METHOD: Change in cortical thickness was estimated from two neuroanatomic MRI scans in 43 youths with ADHD. The mean age at the first scan was 12.5 years, and at the second scan, 16.4 years. Nineteen patients not treated with psychostimulants between the scans were compared with an age-matched group of 24 patients who were treated with psychostimulants. Further comparison was made against a template derived from 620 scans of 294 typically developing youths without ADHD. RESULTS: Adolescents taking psychostimulants differed from those not taking psychostimulants in the rate of change of the cortical thickness in the right motor strip, the left middle/inferior frontal gyrus, and the right parieto-occipital region. The group difference was due to more rapid cortical thinning in the group not taking psychostimulants (mean cortical thinning of 0.16 mm/year [SD=0.17], compared with 0.03 mm/year [SD=0.11] in the group taking psychostimulants). Comparison against the typically developing cohort without ADHD showed that cortical thinning in the group not taking psychostimulants was in excess of age-appropriate rates. The treatment groups did not differ in clinical outcome, however. CONCLUSIONS: These findings show no evidence that psychostimulants were associated with slowing of overall growth of the cortical mantle.
Authors: Rhoshel K Lenroot; Nitin Gogtay; Deanna K Greenstein; Elizabeth Molloy Wells; Gregory L Wallace; Liv S Clasen; Jonathan D Blumenthal; Jason Lerch; Alex P Zijdenbos; Alan C Evans; Paul M Thompson; Jay N Giedd Journal: Neuroimage Date: 2007-04-06 Impact factor: 6.556
Authors: James Swanson; Laurence Greenhill; Tim Wigal; Scott Kollins; Annamarie Stehli; Mark Davies; Shirley Chuang; Benedetto Vitiello; Anne Skrobala; Kelly Posner; Howard Abikoff; Melvin Oatis; James McCRACKEN; James McGOUGH; Mark Riddle; Jaswinder Ghuman; Charles Cunningham; Sharon Wigal Journal: J Am Acad Child Adolesc Psychiatry Date: 2006-11 Impact factor: 8.829
Authors: P Shaw; K Eckstrand; W Sharp; J Blumenthal; J P Lerch; D Greenstein; L Clasen; A Evans; J Giedd; J L Rapoport Journal: Proc Natl Acad Sci U S A Date: 2007-11-16 Impact factor: 11.205
Authors: F Xavier Castellanos; Patti P Lee; Wendy Sharp; Neal O Jeffries; Deanna K Greenstein; Liv S Clasen; Jonathan D Blumenthal; Regina S James; Christen L Ebens; James M Walter; Alex Zijdenbos; Alan C Evans; Jay N Giedd; Judith L Rapoport Journal: JAMA Date: 2002-10-09 Impact factor: 56.272
Authors: L J S Schweren; C A Hartman; M P Zwiers; D J Heslenfeld; D van der Meer; B Franke; J Oosterlaan; J K Buitelaar; P J Hoekstra Journal: Eur Child Adolesc Psychiatry Date: 2014-11-14 Impact factor: 4.785
Authors: Erika Proal; Philip T Reiss; Rachel G Klein; Salvatore Mannuzza; Kristin Gotimer; Maria A Ramos-Olazagasti; Jason P Lerch; Yong He; Alex Zijdenbos; Clare Kelly; Michael P Milham; F Xavier Castellanos Journal: Arch Gen Psychiatry Date: 2011-11
Authors: Lisa A Jacobson; Matthew Ryan; Rebecca B Martin; Joshua Ewen; Stewart H Mostofsky; Martha B Denckla; E Mark Mahone Journal: Child Neuropsychol Date: 2011 Impact factor: 2.500
Authors: Thomas J Spencer; Ariel Brown; Larry J Seidman; Eve M Valera; Nikos Makris; Alexandra Lomedico; Stephen V Faraone; Joseph Biederman Journal: J Clin Psychiatry Date: 2013-09 Impact factor: 4.384
Authors: Madeline M Robertson; Sarah Furlong; Bradley Voytek; Thomas Donoghue; Charlotte A Boettiger; Margaret A Sheridan Journal: J Neurophysiol Date: 2019-10-16 Impact factor: 2.714
Authors: Eliza Congdon; Lori L Altshuler; Jeanette A Mumford; Katherine H Karlsgodt; Fred W Sabb; Joseph Ventura; James J McGough; Edythe D London; Tyrone D Cannon; Robert M Bilder; Russell A Poldrack Journal: Psychiatry Res Date: 2014-02-13 Impact factor: 3.222